Wedbush Securities Inc Trinity Biotech PLC Transaction History

Wedbush Securities Inc

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2020 Oct 20, 2020	SELL	$1.68 - $3.17 $23,520 - $44,380	-14,000 Closed	0 $0
Q2 2020 Jul 16, 2020	BUY	$0.88 - $2.55 $12,320 - $35,700	14,000 New	14,000 $31,000
Q1 2019 Apr 17, 2019	SELL	$2.31 - $3.22 $27,304 - $38,060	-11,820 Closed	0 $0
Q4 2018 Jan 31, 2019	SELL	$2.14 - $4.26 $9,523 - $18,957	-4,450 Reduced 27.35%	11,820 $27,000
Q3 2018 Nov 13, 2018	SELL	$3.76 - $5.08 $1,316 - $1,778	-350 Reduced 2.11%	16,270 $65,000
Q2 2018 Aug 03, 2018	SELL	$4.46 - $5.2 $6,154 - $7,176	-1,380 Reduced 7.67%	16,620 $83,000
Q1 2018 May 01, 2018	SELL	$5.08 - $6.06 $30,988 - $36,966	-6,100 Reduced 25.31%	18,000 $93,000
Q4 2017 Feb 09, 2018	SELL	$4.5 - $5.77 $16,875 - $21,637	-3,750 Reduced 13.46%	24,100 $123,000
Q3 2017 Oct 31, 2017	BUY	$5.16 - $5.67 $143,706 - $157,909	27,850	27,850 $156,000

30.2K

Ticker TRIB
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 38,107,600
Market Cap $46.5M
Description
Trinity Biotech plc acquires, develops, manufactures, and markets medical diagnostic products for the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas, Africa, Asia, and Europe. The company offers clinical laboratory products, including diagnostic tests and instrumentation, which detect infectious dis...

Get notified when there are updates to the investment portfolio of Wedbush Securities Inc, based on Form 13F filings with the SEC.

Stay updated on Wedbush Securities Inc with notifications on news.